Antibody-Positive Type 1 Diabetes in a Family With a Pathogenic <i>HNF1A</i>-MODY Variant and Variable Age of Onset
Monogenic diabetes (MD) is a relatively rare and heterogeneous group of disorders caused by pathogenic single-gene variants or abnormalities resulting in hyperglycemia. MD represents approximately 3.5% of all diabetes cases diagnosed before age 35 years, though it is possible for MD to develop at later ages. MD diagnoses have implications for precision therapy and cascade genetic testing. A hallmark characteristic suggesting MD is a multigenerational family history of nonobese diabetes diagnosed before age 35 with an autosomal dominant inheritance. However, even with a known family history of genetically confirmed MD, it is possible for an individual within that family to have a different form of diabetes. Here, we present a case from the University of Chicago Monogenic Diabetes Registry of an individual with antibody-positive type 1 diabetes in a family with a history of a genetically confirmed known pathogenic <i>HNF1A</i> variant causing maturity-onset diabetes of the young (MODY) with variable age of onset in affected individuals. This family pedigree showcases that <i>HNF1A</i>-MODY can develop at any age and illustrates the importance of every individual receiving a thorough work-up for accurate diabetes classification, including obtaining antibody testing and genetic testing, when indicated, to provide optimal treatment and management.
Authors
- Siri Atma W. Greeley (ORCID: https://orcid.org/0000-0002-0741-3567)
- Rochelle N. Naylor (ORCID: https://orcid.org/0000-0003-1753-8328)
- Louis H. Philipson (ORCID: https://orcid.org/0000-0002-2208-3607)
- A Dye
- Balamurugan Kandasamy
- Michael E. McCullough (ORCID: https://orcid.org/0009-0006-0470-4429)
Institutions
- Diabetes Australia (AU)
- University of Chicago (US)
Publication Details
- Journal
- JCEM Case Reports
- Published
- 2025-09-25
- DOI
- https://doi.org/10.1210/jcemcr/luaf229
- Primary Topic
- Diabetes and associated disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Kovler Family Foundation
- Georgia Clinical and Translational Science Alliance
- National Institutes of Health
- Directorate for Biological Sciences
- National Institute of Diabetes and Digestive and Kidney Diseases